Browse > Article

Prevalence and Survival Patterns of Patients with Bone Metastasis from Common Cancers in Thailand  

Phanphaisarn, Areerak (Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University)
Patumanond, Jayantorn (Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University)
Settakorn, Jongkolnee (Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University)
Chaiyawat, Parunya (Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University)
Klangjorhor, Jeerawan (Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University)
Pruksakorn, Dumnoensun (Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.17, no.9, 2016 , pp. 4335-4340 More about this Journal
Abstract
Background: Bone metastasis is a single condition but presents with various patterns and severities. Skeletal-related events (SREs) deteriorate overall performance status and reduce quality of life. However, guidelines for early detection and management are limited. This study includes a survey of the prevalence of bone metastasis in cases with common cancers in Thailand as well as a focus on survival patterns and SREs. Materials and Methods: A retrospective cohort analysis was conducted using a database of the Chiang Mai Cancer Registry and the Musculoskeletal Tumor Registry of the OLARN Center, Chiang Mai University. The prevalence of bone metastasis from each type of primary cancer was noted and time-to-event analysis was performed to estimate cancer survival rates after bone metastasis. Results: There were 29,447 cases of the ten most common cancers in Thailand, accounting for 82.2% of the entire cancer registry entries during the study period. Among those cases, there were 2,263 with bone metastases, accounting for 7.68% of entries. Bone metastasis from lung, liver, breast, cervix and prostate are common in the Thai population, accounting for 83.4% of all positive cases. The median survival time of all was 6 months. Of the bone metastases, 48.9% required therapeutic intervention, including treatment of spinal cord and nerve root compression, pathological fractures, and bone pain. Conclusions: The frequency of the top five types of bone metastasis in Thailand were different from the frequencies in other countries, but corresponded to the relative prevalence of the cancers in Thailand and osteophilic properties of each cancer. The results of this study support the establishment of country specific guidelines for primary cancer identification with skeletal lesions of unknown origin. In addition, further clinical studies of the top five bone metastases should be performed to develop guidelines for optimal patient management during palliative care.
Keywords
Bone metastasis; prevalence; survival rate; skeletal-related events; Thailand;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Uchino K, Tateishi R, Shiina S, et al (2011). Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer, 117, 4475-83.   DOI
2 Zoccali C, Skoch J, Walter CM, et al (2016). The Tokuhashi score: effectiveness and pitfalls. Eur Spine J, 25, 673-8.   DOI
3 Abbas A, Medvedev S, Shores N, et al (2014). Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig Dis Sci, 59, 2813-20.   DOI
4 Bae HM, Lee SH, Kim TM, et al (2012). Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. Lung Cancer, 77, 572-7.   DOI
5 Coleman RE (2001). Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev, 27, 165-76.   DOI
6 Coleman RE (2006). Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res, 12, 6243s-9s.   DOI
7 D'Addario G, Fruh M, Reck M, et al (2010). Metastatic nonsmall-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 116-9.   DOI
8 Goodwin CR, Abu-Bonsrah N, Boone C, et al (2016). Nonhepatocellular carcinoma spinal metastases. J Clin Neurosci, 27, 22-7.   DOI
9 Ibrahim T, Mercatali L, Amadori D (2013). A new emergency in oncology: Bone metastases in breast cancer patients (Review). Oncol Lett, 6, 306-10.   DOI
10 Habermehl D, Haase K, Rieken S, et al (2011). Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: an analysis of survival and treatment efficacy. Tumori, 97, 609-13.   DOI
11 Li S, Peng Y, Weinhandl ED, et al (2012). Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol, 4, 87-93.
12 Katayose Y, Nakagawa K, Yamamoto K, et al (2012). Lymph nodes metastasis is a risk factor for bone metastasis from extrahepatic cholangiocarcinoma. Hepatogastroenterol, 59, 1758-60.
13 Khuntikeo N, Chamadol N, Yongvanit P, et al (2015). Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer, 15, 459.   DOI
14 Kim SU, Kim DY, Park JY, et al (2008). Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors. J Cancer Res Clin Oncol, 134, 1377-84.   DOI
15 Nguyen DX, Bos PD, Massague J (2009). Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer, 9, 274-84.   DOI
16 Liede A, Jerzak KJ, Hernandez RK, et al (2016). The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Res Treat, 156, 587-95.   DOI
17 Makino H, Nishio S, Tsubamoto H, et al (2016). Treatment and prognosis of bone metastasis from cervical cancer (KCOGG1202s). J Obstet Gynaecol Res.
18 McDougall JA, Bansal A, Goulart BH, et al (2016). The clinical and economic impacts of skeletal-related events among medicare enrollees with prostate cancer metastatic to bone. Oncologist, 21, 320-6.   DOI
19 Oster G, Lamerato L, Glass AG, et al (2013). Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer, 21, 3279-86.   DOI
20 Paholpak P, Sirichativapee W, Wisanuyotin T, et al (2012). Prevalence of known and unknown primary tumor sites in spinal metastasis patients. Open Orthop J, 6, 440-4.   DOI
21 Tarnoki DL, Tarnoki AD, Ohlmann-Knafo S, et al (2016). Pattern of Tumour Spread of Common Primary Tumours as Seen on Magnetic Resonance Imaging. Pathol Oncol Res, 22, 79-85.   DOI
22 Qiu ZL, Song HJ, Xu YH, et al (2011). Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab, 96, 3078-86.   DOI
23 Singh VA, Haseeb A, Alkubaisi AA (2014). Incidence and outcome of bone metastatic disease at University Malaya Medical Centre. Singapore Med J, 55, 539-46.   DOI
24 Sugino K, Kameyama K, Nagahama M, et al (2014). Follicular thyroid carcinoma with distant metastasis: outcome and prognostic factor. Endocr J, 61, 273-9.   DOI
25 Takagi T, Katagiri H, Kim Y, et al (2015). Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases. PLoS One, 10, 129428.
26 Tanaka R, Yonemori K, Hirakawa A, et al (2016). Risk factors for developing skeletal-related events in breast cancer patients with bone metastases undergoing treatment with bone-modifying agents. Oncologist, 21, 508-13.   DOI
27 Thanapprapasr D, Nartthanarung A, Likittanasombut P, et al (2010). Bone metastasis in cervical cancer patients over a 10-year period. Int J Gynecol Cancer, 20, 373-8.   DOI
28 Thunyaharn N, Promthet S, Wiangnon S, et al (2013). Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev, 14, 7029-32.   DOI
29 Tomita K, Kawahara N, Kobayashi T, et al (2001). Surgical strategy for spinal metastases. Spine, 26, 298-306.   DOI
30 Tsuya A, Kurata T, Tamura K, et al (2007). Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer, 57, 229-32.   DOI